JNJ-77242113 (Icotrokinra)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-77242113 (Icotrokinra), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis [Phase 3]